Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effectsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32012-06-1166OAAI
Effect of Altered AGP Plasma Binding on Heart Rate Changes by S(-)-Propranolol in Rats Using Mechanism-Based Estimations of In Vivo Receptor Affinity (KB,vivo)JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82010-05-016PREAI
Influence of Plasma Protein Binding on Pharmacodynamics: Estimation of In Vivo Receptor Affinities of β Blockers Using a New Mechanism-Based PK-PD Modelling ApproachJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82009-10-0114PREAI
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated effluxBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2946OAAI
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEGBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2919OAAI
Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenalineinduced tachycardia as a continuous pharmacodynamic endpointBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2923OAAI
Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortexBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-299OAAI
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: The role of complex biophase distribution kineticsEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72008-07-0123OA
Mechanism-based pharmacodynamic modeling of s(-)-atenolol:: Estimation of in vivo affinity for the β1-adrenoceptor with an agonist-antagonist interaction modelJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82008-03-016PREAI
Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortexEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72008-03-0111PREAI
Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behaviorEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72007-11-013PREAI
Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the ratPHARMACEUTICAL RESEARCHIF4.32007-08-2125OAAI
Population pharmacokinetic model of fluvoxamine in rats: Utility for application in animal behavioral studiesEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72007-01-0111PREAI